Rani Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.03-$7.88
Market Cap
$68.8M
Shares Short
2M

Financials

See more
Revenue (12 Mos)
$1M
Revenue Growth (YoY)
-100%
Gross Profit (12 Mos)
$1M
Diluted EPS
-$1.05

News

See more

Yahoo Finance • 23 days ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Yahoo Finance • 28 days ago

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Yahoo Finance • 29 days ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Yahoo Finance • last year

Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill® Technology Platform; Reports Preliminary Third Quarter 2023 Financial Results

About

CEO
Mr. Talat Imran
Address
2051 Ringwood Avenue, San Jose, CA, United States, 95131
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
105